BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10194047)

  • 1. Oral contraceptive use and hemodynamic, lipid, and fibrinogen responses to smoking and stress in women.
    Davis MC
    Health Psychol; 1999 Mar; 18(2):122-30. PubMed ID: 10194047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cigarette smoking and oral contraceptive use influence women's lipid, lipoprotein, and cardiovascular responses during stress.
    Davis MC; Matthews KA
    Health Psychol; 1990; 9(6):717-36. PubMed ID: 2286182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.
    Fruzzetti F; Ricci C; Fioretti P
    Contraception; 1994 Jun; 49(6):579-92. PubMed ID: 8070263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.
    Schwingl PJ; Ory HW; Visness CM
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):241-9. PubMed ID: 9914611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking and cycle control among oral contraceptive users.
    Rosenberg MJ; Waugh MS; Stevens CM
    Am J Obstet Gynecol; 1996 Feb; 174(2):628-32. PubMed ID: 8623797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women.
    Straznicky NE; Barrington VE; Branley P; Louis WJ
    J Hypertens; 1998 Mar; 16(3):357-68. PubMed ID: 9557929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives, smoking and risk of myocardial infarction in young women. A longitudinal population study in eastern Finland.
    Salonen JT
    Acta Med Scand; 1982; 212(3):141-4. PubMed ID: 7148505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking, oral contraceptives, and cardiovascular reactivity to stress.
    Straneva P; Hinderliter A; Wells E; Lenahan H; Girdler S
    Obstet Gynecol; 2000 Jan; 95(1):78-83. PubMed ID: 10636507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An epidemiological study of the haemostatic and other effects of oral contraceptives.
    Meade TW; Brozović M; Chakrabarth R; Howarth DJ; North WR; Stirling Y
    Br J Haematol; 1976 Nov; 34(3):353-64. PubMed ID: 990177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two problems in oral contraception: arteriosclerotic cardiopathy and drug interactions.
    Onnis A; Grella PV; Di Lenardo L
    Clin Exp Obstet Gynecol; 1982; 9(2):61-5. PubMed ID: 7160061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of oral contraceptive use with serum lipids and lipoproteins in young women: the Bogalusa Heart Study.
    Greenlund KJ; Webber LS; Srinivasan S; Wattigney W; Johnson C; Berenson GS
    Ann Epidemiol; 1997 Nov; 7(8):561-7. PubMed ID: 9408552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of cognitive and physical stress on cardiovascular reactivity among smokers and oral contraceptive users.
    Emmons KM; Weidner G
    Psychophysiology; 1988 Mar; 25(2):166-71. PubMed ID: 3399603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
    Lewis MA; Heinemann LA; Spitzer WO; MacRae KD; Bruppacher R
    Contraception; 1997 Sep; 56(3):129-40. PubMed ID: 9347202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease: pathogenesis, epidemiology, and risk among users of oral contraceptives who smoke.
    Castelli WP
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S349-56. PubMed ID: 10368520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking and use of oral contraceptives: impact on thrombotic diseases.
    Lidegaard O
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased blood viscosity in young women using oral contraceptives.
    Lowe GD; Drummond MM; Forbes CD; Barbenel JC
    Am J Obstet Gynecol; 1980 Aug; 137(7):840-2. PubMed ID: 6967698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of arterial disease among oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study.
    J R Coll Gen Pract; 1983 Feb; 33(247):75-82. PubMed ID: 6864638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated intracranial occlusive disease, oral contraceptives, and cigarette use.
    Levine SR; Fagan SC; Pessin MS; Silbergleit R; Floberg J; Selwa JF; Vogel CM; Welch KM
    Neurology; 1991 Dec; 41(12):1893-901. PubMed ID: 1745344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular and mood responses to quantified doses of cigarette smoke in oral contraceptive users and nonusers.
    Masson CL; Gilbert DG
    J Behav Med; 1999 Dec; 22(6):589-604. PubMed ID: 10650538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.